Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
We aim to demonstrate that oral administration of glibenclamide stimulates pancreatic
glucagon secretion during hypoglycemia in insulin-deficient (C-peptide negative) patients
with type 1 diabetes when compared to type 1 diabetic patients with residual insulin
secretion (C-peptide positive).